Department of Paediatrics, Tergooi hospitals, Rijksstraatweg 1, 1261 AN, Blaricum, The Netherlands.
Department of Microbiology, Tergooi hospitals, Blaricum, The Netherlands.
Eur J Pediatr. 2018 May;177(5):741-746. doi: 10.1007/s00431-018-3113-2. Epub 2018 Feb 18.
Significant overtreatment with antibiotics for suspected early onset sepsis (EOS) constitutes a persisting clinical problem, generating unnecessary risks, harms, and costs for many newborns. We aimed to study feasibility and impact of a sepsis calculator to help guide antibiotic for suspected EOS in a European setting. In this single-center study, the sepsis calculator was implemented as an addition to and in accordance with existing protocols. One thousand eight hundred seventy-seven newborns ≥ 35 weeks of gestational age were prospectively evaluated; an analogous retrospective control group (n = 2076) was used for impact analysis. We found that empirical treatment with intravenous antibiotics for suspected EOS was reduced from 4.8 to 2.7% after sepsis calculator implementation (relative risk reduction 44% (95% confidence interval 21.4-59.5%)). No evidence for changes in time to treatment start, treatment duration, or proven sepsis rates was found. Adherence to sepsis calculator recommendation was 91%.
Pragmatic and feasible implementation of the sepsis calculator yields a 44% reduction of empirical use of antibiotics for EOS, without signs of delay or prolongation of treatment. These findings warrant a multicenter, nation-wide, randomized study evaluating systematic use of the sepsis calculator prediction model and its effects in clinical practice outside of the USA. What is known: • Significant overtreatment with antibiotics for suspected early-onset sepsis results in unnecessary costs, risks, and harms. • Implementation of the sepsis calculator in the USA has resulted in a significant decrease in empirical antibiotic treatment, without apparent adverse events. What is new: • Implementation of the sepsis calculator in daily clinical decision-making in a Dutch teaching hospital is feasible in conjunction with existing protocols, with high adherence. • Antibiotic therapy for suspected early-onset sepsis was reduced by 44% following implementation of the calculator.
研究在欧洲环境下,使用败血症计算器指导疑似早发性败血症(EOS)患儿使用抗生素的可行性和影响。
本单中心研究将败血症计算器作为现有方案的补充实施。前瞻性评估了 1877 例胎龄≥35 周的新生儿;使用类似的回顾性对照组(n=2076)进行影响分析。
实施败血症计算器后,疑似 EOS 患儿接受静脉抗生素经验性治疗的比例从 4.8%降至 2.7%(相对风险降低 44%[95%置信区间 21.4%-59.5%])。未发现治疗开始时间、治疗持续时间或确诊败血症率的变化。败血症计算器建议的依从率为 91%。
败血症计算器的实用且可行的实施使 EOS 经验性使用抗生素的比例降低了 44%,且无治疗延迟或延长的迹象。这些发现为一项多中心、全国性、随机研究提供了依据,该研究将评估败血症计算器预测模型在除美国以外的临床实践中的系统应用及其效果。